Detection and Analysis of Antibiotic Sensitivity Spectrum for Mycoplasma from STDS Groups
Fang Si
Abstract
Fang Si
Abstract
Objective To understand the mycoplasma infection and drug resistance of mycoplasma from the urogenital samples of STD patients.Methods Mycoplasma detection kit was used to detect mycoplasma and its sensitivity to different antibiotics in 186 cases suspected with nongonococcal urethritis (NGU). Results 88 cases were mycoplasma positive (47 73%). 47 cases were Ureaplasma urealytcum(Uu) positive (25 27%). The cultured mycoplasma was sensitive to josamycin (97 7%), azithromycin (96 6%), doxycycline (94 3%), roxithromycin (90 9%), ofloxacin (88 6%), minocyclin (87 5%), norfloxacin (80 7%), spirmycin (73 9%), erythromycin (72 7%), and tetracycline (67%). Conclusion Josamycin, azithromycin, doxycycline, and roxithromycin should be chosen to treat mycoplasma infection in the first trial. Tetracycline should not be chosen for the treatment of mycoplasma infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To understand the mycoplasma infection and drug resistance of mycoplasma from the urogenital samples of STD patients.Methods Mycoplasma detection kit was used to detect mycoplasma and its sensitivity to different antibiotics in 186 cases suspected with nongonococcal urethritis (NGU). Results 88 cases were mycoplasma positive (47 73%). 47 cases were Ureaplasma urealytcum(Uu) positive (25 27%). The cultured mycoplasma was sensitive to josamycin (97 7%), azithromycin (96 6%), doxycycline (94 3%), roxithromycin (90 9%), ofloxacin (88 6%), minocyclin (87 5%), norfloxacin (80 7%), spirmycin (73 9%), erythromycin (72 7%), and tetracycline (67%). Conclusion Josamycin, azithromycin, doxycycline, and roxithromycin should be chosen to treat mycoplasma infection in the first trial. Tetracycline should not be chosen for the treatment of mycoplasma infection.
Key concepts: Josamycin, Roxithromycin, Mycoplasma, Urethritis, Mycoplasma hominis, Doxycycline, Azithromycin, Ureaplasma